Related Experiment Video
Updated: Jun 20, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
3.9K
Transcatheter Therapy for Mitral Valve Stenosis
1Oregon Health and Science University, Portland, OR, USA.
Cardiology Clinics
|June 23, 2024
Summary
Mitral valve stenosis is common and changing. This review covers transcatheter therapies for mitral valve stenosis, addressing rheumatic and degenerative causes in diverse populations.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Background:
- Mitral valve stenosis (MVS) remains a significant public health concern in the US, with evolving patient demographics.
- Rheumatic heart disease causing MVS persists globally, and migration patterns introduce it to developed nations.
- An aging population and increased cardiovascular risk factors contribute to degenerative MVS and failure of prior valve interventions.
Purpose of the Study:
- To review current transcatheter therapeutic options for managing mitral valve stenosis.
- To provide an overview of evolving treatment strategies for this prevalent valvular heart disease.
Main Methods:
- Systematic literature review of transcatheter therapies for mitral valve stenosis.
- Analysis of demographic trends and etiological factors contributing to MVS prevalence.
- Evaluation of the efficacy and safety of various transcatheter interventions.
Main Results:
- Transcatheter therapies offer promising alternatives for MVS treatment, particularly in high-risk surgical candidates.
- Emerging techniques demonstrate feasibility and positive outcomes in managing both rheumatic and degenerative MVS.
- The landscape of MVS treatment is shifting towards less invasive, transcatheter approaches.
Conclusions:
- Transcatheter interventions represent a growing and vital treatment modality for mitral valve stenosis.
- Understanding the changing epidemiology of MVS is crucial for tailoring therapeutic strategies.
- Continued research and development in transcatheter therapies are essential for improving patient outcomes.
Keywords:
Mitral valve stenosisRheumatic valvular diseaseStructural cardiologyTranscatheter therapiesMore Related Videos
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...